glp 1 nano microneedle patch Lmipki Review LBMLBM GLP-1 Slimming and health

doi:10.1016/j.fertnstert.2016.05.003 Mendoza N, Diaz-Ropero MP, Aragon M, et al

The PROTECT study and other trials have confirmed its ability to preserve beta-cell function and prolong the preclinical phase of the disease, offering hope for strategies aimed at intercepting T1D before its clinical manifestation (130)

Injectable GHK-Cu timing For those using injectable GHK-Cu , timing considerations change significantly

Disappointing GLP-1 Results in Alzheimers Trial: Underscores Promise (and Limits) of Single-Agent Approaches Key takeaways Two large Phase 3 trials (EVOKE and EVOKE+) of oral semaglutide (a GLP1 receptor agonist) in early Alzheimers disease showed no significant slowing of cognitive or functional decline vs

Metformin also affects AMPK activity, which is one reason the two get compared

Jiang, J., & Xiong, Y